COVID-19 pandemic and impact on coverage of HIV screening for risk groups

Abstract

COVID-19 pandemic is an important global problem.[1] It causes a lot of problems in public health and medicine. In HIV medicine, it is reported that COVID-19 pandemic can cause antiretroviral treatment interruption among people living with HIV and might further result in poor control of HIV spread. In addition to the antiretroviral drug interruption problem, the COVID-19 outbreak can also result in difficulty in active cases searching for an early diagnosis of HIV.